# Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study

> **NCT02486445** · PHASE3 · COMPLETED · sponsor: **Ostfold Hospital Trust** · enrollment: 625 (actual)

## Conditions studied

- Deep Venous Thrombosis

## Interventions

- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT02486445
- **Lead sponsor:** Ostfold Hospital Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 625 (ACTUAL)
- **Last updated:** 2019-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02486445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02486445, "Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study". Retrieved via MORVS 2026-10-08 from https://api.morvs.ai/clinical/NCT02486445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*